Rolf Jan Rutten

Rolf Rutten is a seasoned professional with a diverse background in the fields of biotechnology, healthcare, and business development.

He holds a degree from Wageningen University & Research, showcasing his strong educational foundation in the industry.

Rolf Rutten's impressive career includes holding prominent positions such as CEO at Audion Therapeutics, demonstrating his leadership skills and strategic vision.

His extensive experience also extends to roles like CEO at Oncosence, Venture Partner at ScaleUpNation, and Founder at Dybly AG and thromboDx, indicating his entrepreneurial spirit and innovation.

Rolf Rutten has a rich history in various organizations, having served as CBO at Delta Crystallon, Managing Director Clinquest Services at Clinquest Group, Director at Clinquest Group, and Director Business Development at TNO Biomedical Research and Kreatech Biotechnology.

Additionally, he has showcased his international expertise by holding positions like Sales Manager, Product Development Manager, and Export Manager Asia and Pacific at Intervet Mexico.